<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Cao N</submitter><pubmed_abstract>&lt;h4>Backgrounds&lt;/h4>Coronary microvascular obstruction (MVO) frequently occurs in patients with ST-segment elevation myocardial infarction (STEMI) following percutaneous coronary intervention (PCI), leading to poor prognosis. β&lt;sub>1&lt;/sub> adrenergic receptor autoantibodies (β&lt;sub>1&lt;/sub>-AA) are present in various cardiovascular diseases and correlate with cardiac damage and dysfunction. However, whether β&lt;sub>1&lt;/sub>-AA is associated with the occurrence of MVO in patients with STEMI after PCI remains unclear.&lt;h4>Aims&lt;/h4>To investigate the prognostic relationship between β&lt;sub>1&lt;/sub>-AA and the occurrence of MVO in patients with STEMI with post-PCI.&lt;h4>Methods&lt;/h4>This prospective study included 403 patients with STEMI who underwent primary PCI. The patients were divided into MVO+ and M</pubmed_abstract><journal>Journal of translational autoimmunity</journal><pagination>100261</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11615580</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic value of β1 adrenergic receptor autoantibodies for microvascular obstruction in patients with STEMI with Post-PCI: A prospective cohort study.</pubmed_title><pmcid>PMC11615580</pmcid><pubmed_authors>Cao N</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Guo S</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Dang W</pubmed_authors><pubmed_authors>Xin Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic value of β1 adrenergic receptor autoantibodies for microvascular obstruction in patients with STEMI with Post-PCI: A prospective cohort study.</name><description>&lt;h4>Backgrounds&lt;/h4>Coronary microvascular obstruction (MVO) frequently occurs in patients with ST-segment elevation myocardial infarction (STEMI) following percutaneous coronary intervention (PCI), leading to poor prognosis. β&lt;sub>1&lt;/sub> adrenergic receptor autoantibodies (β&lt;sub>1&lt;/sub>-AA) are present in various cardiovascular diseases and correlate with cardiac damage and dysfunction. However, whether β&lt;sub>1&lt;/sub>-AA is associated with the occurrence of MVO in patients with STEMI after PCI remains unclear.&lt;h4>Aims&lt;/h4>To investigate the prognostic relationship between β&lt;sub>1&lt;/sub>-AA and the occurrence of MVO in patients with STEMI with post-PCI.&lt;h4>Methods&lt;/h4>This prospective study included 403 patients with STEMI who underwent primary PCI. The patients were divided into MVO+ and M</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-02T22:08:16.164Z</modification><creation>2025-04-04T01:56:59.341Z</creation></dates><accession>S-EPMC11615580</accession><cross_references><pubmed>39634465</pubmed><doi>10.1016/j.jtauto.2024.100261</doi></cross_references></HashMap>